Iovance Biotherapeutics (IOVA) Earnings
|
Expand Research on IOVA
| Next EPS Date | 8/6/26 | EPS Growth Rate | +60.6% |
|---|---|---|---|
| Average EPS % Beat Rate | -27.4% | Revenue Growth Rate | +46.1% |
| Average % Move 1-Wk after EPS | -9.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$0.13 | N/A | N/A | $87.68M | = | N/A | N/A | ||
| 5/7/26 | Q126 | -$0.19 | -$0.14 | -$0.05 | $71.43M | $80.93M | = |  | | Details | |
| 2/24/26 | Q425 | -$0.18 | -$0.17 | -$0.01 | $86.71M | $82.03M | N/A | | | Details | |
| 11/6/25 |
Q325 | N/A | -$0.26 | N/A | N/A | $76.19M | = | N/A | N/A | ||
| 8/7/25 | Q225 | -$0.33 | -$0.28 | -$0.05 | $60M | $67.1M | = | | | Details | |
| 5/8/25 | Q125 | -$0.36 | -$0.24 | -$0.12 | $49.3M | $83.27M | = | | | Details | |
| 2/27/25 | Q424 | -$0.26 | -$0.27 | +$0.01 | $73.69M | $77.33M | = | | | Details | |
| 11/7/24 | Q324 | -$0.28 | -$0.30 | +$0.02 | $58.6M | $53.88M | N/A | | | Details |
